Sermorelin Acetate

Sermorelin Acetate — Research Peptide

Sermorelin Acetate is a synthetic peptide analog of growth hormone-releasing hormone (GHRH 1-29) commonly studied in laboratory settings for its interaction with pituitary signaling pathways, growth hormone secretion mechanisms, and endocrine system regulation. As a truncated analog of endogenous GHRH, Sermorelin has been widely researched for its role in peptide-mediated hormonal signaling and cellular communication processes.

Scientific literature has explored Sermorelin in studies involving growth hormone pulsatility, insulin-like growth factor-1 (IGF-1) signaling, pituitary receptor activity, and metabolic pathway research. Additional studies have examined how Sermorelin interacts with GHRH receptors and influences endocrine signaling mechanisms in experimental models.

Published research has investigated Sermorelin in laboratory models involving hormone regulation, cellular metabolism, peptide signaling pathways, and biochemical communication systems. Research has also explored its role in endocrine pathway analysis and growth hormone-related molecular signaling studies.

This compound is supplied for qualified laboratory research and analytical purposes only.

Product Details

Product Name: Sermorelin Acetate
Alternative Name: GHRH 1-29 Analog
Form: Lyophilized peptide powder
Grade: Research use only
Application: Laboratory research and analytical testing only
Storage: Store in a cool, dry place under proper laboratory storage conditions.

Research Areas

This compound may be used in research related to:

• Growth hormone-releasing hormone (GHRH) pathway studies
• Pituitary and endocrine signaling research
• IGF-1 and metabolic signaling investigation
• Hormonal regulation and receptor activity analysis
• Peptide-mediated cellular communication studies
• Endocrine pathway and biochemical signaling research
• Cellular metabolism and molecular signaling investigation

Research References

• Gelato MC. “Sermorelin: a review of pharmacological and clinical studies.” Clinical Therapeutics.
• Smith RG, Van der Ploeg LH, Howard AD, et al. “Growth hormone secretagogue and GHRH signaling pathways.” Endocrine Reviews.
• Ghigo E, Arvat E, Muccioli G, Camanni F. “Growth hormone-releasing peptides and endocrine research.” European Journal of Endocrinology.

Important Disclaimer

For research use only. Not for human use. Not for animal use. Not for consumption, injection, ingestion, cosmetic use, medical use, veterinary use, or therapeutic application. This product is not intended to diagnose, treat, cure, or prevent any disease. Must be handled only by qualified professionals in a controlled laboratory setting.

Due to current demand and supply availability, peptide vial cap colors may vary. Cap color is determined by available laboratory packaging materials and does not indicate any difference in product identity, specifications, or quality.

Lorem ipsum dolor ist amte, consectetuer adipiscing eilt. Aenean commodo ligula egget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quak felis, ultricies nec, pellentesque eu, pretium quid, sem.